ORTHOPEDIATRICS CORP (KIDS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 90M 180M 270M FY16: 37.3M FY17: 45.6M FY18: 57.6M FY19: 72.6M FY20: 71.1M FY21: 98M FY22: 122.3M FY23: 148.7M FY24: 204.7M FY25: 236.3M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 60M 120M 180M FY16: 26.4M FY17: 34.5M FY18: 42.7M FY19: 54.6M FY20: 55M FY21: 73.4M FY22: 90.7M FY23: 111.3M FY24: 148.6M FY25: 172.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY16: -6.1M FY17: -6.5M FY18: -9.6M FY19: -9.1M FY20: -26.8M FY21: -18M FY22: -25.4M FY23: -26.8M FY24: -35M FY25: -39.2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY16: -6.6M FY17: -8.9M FY18: -12M FY19: -13.7M FY20: -32.9M FY21: -16.3M FY22: 1.3M FY23: -21M FY24: -37.8M FY25: -39.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 25M 50M 75M FY16: 10.9M FY17: 11.2M FY18: 14.9M FY19: 17.9M FY20: 16M FY21: 24.6M FY22: 31.6M FY23: 37.5M FY24: 56.1M FY25: 63.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY16: -1.1M FY17: -7.2M FY18: -15.6M FY19: -17.8M FY20: -18.5M FY21: -13.1M FY22: -21.8M FY23: -27M FY24: -27M FY25: -4.9M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY16: -5.5M FY17: -12.4M FY18: -20.8M FY19: -29.6M FY20: -29M FY21: -21.2M FY22: -31.8M FY23: -43.9M FY24: -41.3M FY25: -16M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 8M 16M 24M FY19: 14.6M FY20: 18.1M FY21: 19.3M FY22: 20.9M FY23: 22.7M FY24: 23.1M FY25: 23.5M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '16: -7.14 Q1 '17: -6.93 Q2 '17: -7.52 Q3 '17: -7.84 Q4 '17: -6.22 Q1 '18: -5.08 Q2 '18: -3.73 Q3 '18: -2.18 Q4 '18: -0.96 Q1 '19: -0.76 Q2 '19: -0.73 Q3 '19: -0.76 Q4 '19: -0.93 Q1 '20: -1.02 Q2 '20: -1.38 Q3 '20: -1.44 Q4 '20: -1.81 Q1 '21: -2.05 Q2 '21: -1.70 Q3 '21: -1.57 Q4 '21: -0.84 Q1 '22: -0.77 Q2 '22: -0.60 Q3 '22: 0.38 Q4 '22: 0.06 Q1 '23: 0.23 Q2 '23: 0.12 Q3 '23: -0.95 Q4 '23: -0.92 Q1 '24: -0.96 Q2 '24: -1.09 Q3 '24: -1.23 Q4 '24: -1.64 Q1 '25: -1.76 Q2 '25: -1.80 Q3 '25: -1.96 Q4 '25: -1.69 Q1 '26: -1.68 Q2 '26: -1.68 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.